BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26124315)

  • 21. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
    Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
    J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
    Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
    Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
    Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
    Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour.
    László T; Matolcsy A
    Histopathology; 1999 Oct; 35(4):355-9. PubMed ID: 10564390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma.
    Zhu Y; Hollmén J; Räty R; Aalto Y; Nagy B; Elonen E; Kere J; Mannila H; Franssila K; Knuutila S
    Br J Haematol; 2002 Dec; 119(4):905-15. PubMed ID: 12472567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
    Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
    Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study.
    Xu Y; McKenna RW; Kroft SH
    Am J Clin Pathol; 2002 Feb; 117(2):291-300. PubMed ID: 11863226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mantle cell lymphoma diagnosis].
    Choukri M; Taheri H; Seddik R; Benkirane S; Hamama A; Masrar A; Agoumi NB; Chabraoui L
    Ann Biol Clin (Paris); 2013; 71(1):107-12. PubMed ID: 23396434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways.
    Rizzatti EG; Falcão RP; Panepucci RA; Proto-Siqueira R; Anselmo-Lima WT; Okamoto OK; Zago MA
    Br J Haematol; 2005 Aug; 130(4):516-26. PubMed ID: 16098065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathology of mantle cell lymphoma.
    Klapper W
    Semin Hematol; 2011 Jul; 48(3):148-54. PubMed ID: 21782056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cell cycle regulating proteins in an unusual transformation of mantle cell lymphoma.
    Tamaru J; Kawana H; Takahashi Y; Takahashi N; Isobe K; Hirai A; Saito Y; Harigaya K; Itoyama S; Mikata A
    Leuk Lymphoma; 1999 Dec; 36(1-2):129-37. PubMed ID: 10613457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells.
    Agathangelidis A; Hadzidimitriou A; Rosenquist R; Stamatopoulos K
    Semin Cancer Biol; 2011 Nov; 21(5):299-307. PubMed ID: 21946621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
    Clot G; Jares P; Giné E; Navarro A; Royo C; Pinyol M; Martín-Garcia D; Demajo S; Espinet B; Salar A; Ferrer A; Muntañola A; Aymerich M; Rauert-Wunderlich H; Jaffe ES; Connors JM; Gascoyne RD; Delabie J; López-Guillermo A; Ott G; Wright GW; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; Beà S; Campo E
    Blood; 2018 Jul; 132(4):413-422. PubMed ID: 29769262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.
    Iqbal J; Shen Y; Liu Y; Fu K; Jaffe ES; Liu C; Liu Z; Lachel CM; Deffenbacher K; Greiner TC; Vose JM; Bhagavathi S; Staudt LM; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; McKeithan TW; Chan WC
    Blood; 2012 May; 119(21):4939-48. PubMed ID: 22490335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.